 | • レポートコード：MRC2-11QY10864 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗凝固療法のグローバル市場について調査・分析したレポートです。種類別（NOAC、ワルファリン）市場規模、用途別（院内クリニック、独立クリニック、薬局ベースクリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗凝固療法の競争状況、市場シェア ・世界の抗凝固療法市場：種類別市場規模 2015年-2020年（NOAC、ワルファリン） ・世界の抗凝固療法市場：種類別市場規模予測 2021年-2026年（NOAC、ワルファリン） ・世界の抗凝固療法市場：用途別市場規模 2015年-2020年（院内クリニック、独立クリニック、薬局ベースクリニック） ・世界の抗凝固療法市場：用途別市場規模予測 2021年-2026年（院内クリニック、独立クリニック、薬局ベースクリニック） ・北米の抗凝固療法市場分析：米国、カナダ ・ヨーロッパの抗凝固療法市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗凝固療法市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗凝固療法市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗凝固療法市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：CH Boehringer Sohn、Bristol-Myers Squibb、Johnson＆Johnson、Pfizer、Daiichi Sankyo、Portola Pharmaceuticals、Roche、Abbott ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Anticoagulants, commonly referred to as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, blood transfusion bags, and dialysis equipment.
Novel Oral Anticoagulants (NOACs) have major pharmacologic benefits over warfarin, which is a vitamin K antagonist, together with the rapid onset/offset of action, few drug interactions and predictable pharmacokinetics. Warfarin has a limited therapeutic window that can be strike by factors such as diet and enabling patients on warfarin to monitor their INR regularly. Novel oral anticoagulant (NOACs) is the top performing segment as an alternative to anticoagulant. Increasing number of patients with lifelong medical aid therapy, growing prevalence of blood vessel thromboembolism, arrhythmia, and stroke, acceptance of NOAC’s is raising revenue in the market, rising outpatient anticoagulation therapy, increasing number of pipeline products under clinical trials and rising heparin trade spurring the growth of anticoagulation therapy market. However, high cost of developing drugs and risk of malfunctions like increased bleeding is main issue with newer agents are expected to impact the target market negatively.
Market Analysis and Insights: Global Anticoagulation Therapy Market
The global Anticoagulation Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anticoagulation Therapy Scope and Market Size
Anticoagulation Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anticoagulation Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
CH Boehringer Sohn
Bristol-Myers Squibb
Johnson＆Johnson
Pfizer
Daiichi Sankyo
Portola Pharmaceuticals
Roche
Abbott
Market segment by Type, the product can be split into
NOACs
Warfarin
Market segment by Application, split into
Hospital Associated Clinics
Independent Clinics
Pharmacy-Based Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anticoagulation Therapy Revenue
1.4 Market by Type
1.4.1 Global Anticoagulation Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 NOACs
1.4.3 Warfarin
1.5 Market by Application
1.5.1 Global Anticoagulation Therapy Market Share by Application: 2020 VS 2026
1.5.2 Hospital Associated Clinics
1.5.3 Independent Clinics
1.5.4 Pharmacy-Based Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Anticoagulation Therapy Market Perspective (2015-2026)
2.2 Global Anticoagulation Therapy Growth Trends by Regions
2.2.1 Anticoagulation Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Anticoagulation Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Anticoagulation Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Anticoagulation Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Anticoagulation Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Anticoagulation Therapy Players by Market Size
3.1.1 Global Top Anticoagulation Therapy Players by Revenue (2015-2020)
3.1.2 Global Anticoagulation Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Anticoagulation Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anticoagulation Therapy Market Concentration Ratio
3.2.1 Global Anticoagulation Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Anticoagulation Therapy Revenue in 2019
3.3 Anticoagulation Therapy Key Players Head office and Area Served
3.4 Key Players Anticoagulation Therapy Product Solution and Service
3.5 Date of Enter into Anticoagulation Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anticoagulation Therapy Historic Market Size by Type (2015-2020)
4.2 Global Anticoagulation Therapy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Anticoagulation Therapy Market Size by Application (2015-2020)
5.2 Global Anticoagulation Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Anticoagulation Therapy Market Size (2015-2020)
6.2 Anticoagulation Therapy Key Players in North America (2019-2020)
6.3 North America Anticoagulation Therapy Market Size by Type (2015-2020)
6.4 North America Anticoagulation Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Anticoagulation Therapy Market Size (2015-2020)
7.2 Anticoagulation Therapy Key Players in Europe (2019-2020)
7.3 Europe Anticoagulation Therapy Market Size by Type (2015-2020)
7.4 Europe Anticoagulation Therapy Market Size by Application (2015-2020)
8 China
8.1 China Anticoagulation Therapy Market Size (2015-2020)
8.2 Anticoagulation Therapy Key Players in China (2019-2020)
8.3 China Anticoagulation Therapy Market Size by Type (2015-2020)
8.4 China Anticoagulation Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Anticoagulation Therapy Market Size (2015-2020)
9.2 Anticoagulation Therapy Key Players in Japan (2019-2020)
9.3 Japan Anticoagulation Therapy Market Size by Type (2015-2020)
9.4 Japan Anticoagulation Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Anticoagulation Therapy Market Size (2015-2020)
10.2 Anticoagulation Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anticoagulation Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Anticoagulation Therapy Market Size by Application (2015-2020)
11 India
11.1 India Anticoagulation Therapy Market Size (2015-2020)
11.2 Anticoagulation Therapy Key Players in India (2019-2020)
11.3 India Anticoagulation Therapy Market Size by Type (2015-2020)
11.4 India Anticoagulation Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Anticoagulation Therapy Market Size (2015-2020)
12.2 Anticoagulation Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Anticoagulation Therapy Market Size by Type (2015-2020)
12.4 Central & South America Anticoagulation Therapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 CH Boehringer Sohn
13.1.1 CH Boehringer Sohn Company Details
13.1.2 CH Boehringer Sohn Business Overview
13.1.3 CH Boehringer Sohn Anticoagulation Therapy Introduction
13.1.4 CH Boehringer Sohn Revenue in Anticoagulation Therapy Business (2015-2020))
13.1.5 CH Boehringer Sohn Recent Development
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Details
13.2.2 Bristol-Myers Squibb Business Overview
13.2.3 Bristol-Myers Squibb Anticoagulation Therapy Introduction
13.2.4 Bristol-Myers Squibb Revenue in Anticoagulation Therapy Business (2015-2020)
13.2.5 Bristol-Myers Squibb Recent Development
13.3 Johnson＆Johnson
13.3.1 Johnson＆Johnson Company Details
13.3.2 Johnson＆Johnson Business Overview
13.3.3 Johnson＆Johnson Anticoagulation Therapy Introduction
13.3.4 Johnson＆Johnson Revenue in Anticoagulation Therapy Business (2015-2020)
13.3.5 Johnson＆Johnson Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Anticoagulation Therapy Introduction
13.4.4 Pfizer Revenue in Anticoagulation Therapy Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Daiichi Sankyo
13.5.1 Daiichi Sankyo Company Details
13.5.2 Daiichi Sankyo Business Overview
13.5.3 Daiichi Sankyo Anticoagulation Therapy Introduction
13.5.4 Daiichi Sankyo Revenue in Anticoagulation Therapy Business (2015-2020)
13.5.5 Daiichi Sankyo Recent Development
13.6 Portola Pharmaceuticals
13.6.1 Portola Pharmaceuticals Company Details
13.6.2 Portola Pharmaceuticals Business Overview
13.6.3 Portola Pharmaceuticals Anticoagulation Therapy Introduction
13.6.4 Portola Pharmaceuticals Revenue in Anticoagulation Therapy Business (2015-2020)
13.6.5 Portola Pharmaceuticals Recent Development
13.7 Roche
13.7.1 Roche Company Details
13.7.2 Roche Business Overview
13.7.3 Roche Anticoagulation Therapy Introduction
13.7.4 Roche Revenue in Anticoagulation Therapy Business (2015-2020)
13.7.5 Roche Recent Development
13.8 Abbott
13.8.1 Abbott Company Details
13.8.2 Abbott Business Overview
13.8.3 Abbott Anticoagulation Therapy Introduction
13.8.4 Abbott Revenue in Anticoagulation Therapy Business (2015-2020)
13.8.5 Abbott Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Anticoagulation Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Anticoagulation Therapy Revenue
Table 3. Ranking of Global Top Anticoagulation Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anticoagulation Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of NOACs
Table 6. Key Players of Warfarin
Table 7. Global Anticoagulation Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Anticoagulation Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Anticoagulation Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Anticoagulation Therapy Market Share by Regions (2015-2020)
Table 11. Global Anticoagulation Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Anticoagulation Therapy Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Anticoagulation Therapy Market Growth Strategy
Table 17. Main Points Interviewed from Key Anticoagulation Therapy Players
Table 18. Global Anticoagulation Therapy Revenue by Players (2015-2020) (Million US$)
Table 19. Global Anticoagulation Therapy Market Share by Players (2015-2020)
Table 20. Global Top Anticoagulation Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulation Therapy as of 2019)
Table 21. Global Anticoagulation Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Anticoagulation Therapy Product Solution and Service
Table 24. Date of Enter into Anticoagulation Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Anticoagulation Therapy Market Size by Type (2015-2020) (Million US$)
Table 27. Global Anticoagulation Therapy Market Size Share by Type (2015-2020)
Table 28. Global Anticoagulation Therapy Revenue Market Share by Type (2021-2026)
Table 29. Global Anticoagulation Therapy Market Size Share by Application (2015-2020)
Table 30. Global Anticoagulation Therapy Market Size by Application (2015-2020) (Million US$)
Table 31. Global Anticoagulation Therapy Market Size Share by Application (2021-2026)
Table 32. North America Key Players Anticoagulation Therapy Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Anticoagulation Therapy Market Share (2019-2020)
Table 34. North America Anticoagulation Therapy Market Size by Type (2015-2020) (Million US$)
Table 35. North America Anticoagulation Therapy Market Share by Type (2015-2020)
Table 36. North America Anticoagulation Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. North America Anticoagulation Therapy Market Share by Application (2015-2020)
Table 38. Europe Key Players Anticoagulation Therapy Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Anticoagulation Therapy Market Share (2019-2020)
Table 40. Europe Anticoagulation Therapy Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Anticoagulation Therapy Market Share by Type (2015-2020)
Table 42. Europe Anticoagulation Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Anticoagulation Therapy Market Share by Application (2015-2020)
Table 44. China Key Players Anticoagulation Therapy Revenue (2019-2020) (Million US$)
Table 45. China Key Players Anticoagulation Therapy Market Share (2019-2020)
Table 46. China Anticoagulation Therapy Market Size by Type (2015-2020) (Million US$)
Table 47. China Anticoagulation Therapy Market Share by Type (2015-2020)
Table 48. China Anticoagulation Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. China Anticoagulation Therapy Market Share by Application (2015-2020)
Table 50. Japan Key Players Anticoagulation Therapy Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Anticoagulation Therapy Market Share (2019-2020)
Table 52. Japan Anticoagulation Therapy Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Anticoagulation Therapy Market Share by Type (2015-2020)
Table 54. Japan Anticoagulation Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Anticoagulation Therapy Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Anticoagulation Therapy Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Anticoagulation Therapy Market Share (2019-2020)
Table 58. Southeast Asia Anticoagulation Therapy Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Anticoagulation Therapy Market Share by Type (2015-2020)
Table 60. Southeast Asia Anticoagulation Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Anticoagulation Therapy Market Share by Application (2015-2020)
Table 62. India Key Players Anticoagulation Therapy Revenue (2019-2020) (Million US$)
Table 63. India Key Players Anticoagulation Therapy Market Share (2019-2020)
Table 64. India Anticoagulation Therapy Market Size by Type (2015-2020) (Million US$)
Table 65. India Anticoagulation Therapy Market Share by Type (2015-2020)
Table 66. India Anticoagulation Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. India Anticoagulation Therapy Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Anticoagulation Therapy Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Anticoagulation Therapy Market Share (2019-2020)
Table 70. Central & South America Anticoagulation Therapy Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Anticoagulation Therapy Market Share by Type (2015-2020)
Table 72. Central & South America Anticoagulation Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Anticoagulation Therapy Market Share by Application (2015-2020)
Table 74. CH Boehringer Sohn Company Details
Table 75. CH Boehringer Sohn Business Overview
Table 76. CH Boehringer Sohn Product
Table 77. CH Boehringer Sohn Revenue in Anticoagulation Therapy Business (2015-2020) (Million US$)
Table 78. CH Boehringer Sohn Recent Development
Table 79. Bristol-Myers Squibb Company Details
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Product
Table 82. Bristol-Myers Squibb Revenue in Anticoagulation Therapy Business (2015-2020) (Million US$)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. Johnson＆Johnson Company Details
Table 85. Johnson＆Johnson Business Overview
Table 86. Johnson＆Johnson Product
Table 87. Johnson＆Johnson Revenue in Anticoagulation Therapy Business (2015-2020) (Million US$)
Table 88. Johnson＆Johnson Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Product
Table 92. Pfizer Revenue in Anticoagulation Therapy Business (2015-2020) (Million US$)
Table 93. Pfizer Recent Development
Table 94. Daiichi Sankyo Company Details
Table 95. Daiichi Sankyo Business Overview
Table 96. Daiichi Sankyo Product
Table 97. Daiichi Sankyo Revenue in Anticoagulation Therapy Business (2015-2020) (Million US$)
Table 98. Daiichi Sankyo Recent Development
Table 99. Portola Pharmaceuticals Company Details
Table 100. Portola Pharmaceuticals Business Overview
Table 101. Portola Pharmaceuticals Product
Table 102. Portola Pharmaceuticals Revenue in Anticoagulation Therapy Business (2015-2020) (Million US$)
Table 103. Portola Pharmaceuticals Recent Development
Table 104. Roche Company Details
Table 105. Roche Business Overview
Table 106. Roche Product
Table 107. Roche Revenue in Anticoagulation Therapy Business (2015-2020) (Million US$)
Table 108. Roche Recent Development
Table 109. Abbott Business Overview
Table 110. Abbott Product
Table 111. Abbott Company Details
Table 112. Abbott Revenue in Anticoagulation Therapy Business (2015-2020) (Million US$)
Table 113. Abbott Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anticoagulation Therapy Market Share by Type: 2020 VS 2026
Figure 2. NOACs Features
Figure 3. Warfarin Features
Figure 4. Global Anticoagulation Therapy Market Share by Application: 2020 VS 2026
Figure 5. Hospital Associated Clinics Case Studies
Figure 6. Independent Clinics Case Studies
Figure 7. Pharmacy-Based Clinics Case Studies
Figure 8. Anticoagulation Therapy Report Years Considered
Figure 9. Global Anticoagulation Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Anticoagulation Therapy Market Share by Regions: 2020 VS 2026
Figure 11. Global Anticoagulation Therapy Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Anticoagulation Therapy Market Share by Players in 2019
Figure 14. Global Top Anticoagulation Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulation Therapy as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Anticoagulation Therapy Revenue in 2019
Figure 16. North America Anticoagulation Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Anticoagulation Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Anticoagulation Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Anticoagulation Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Anticoagulation Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Anticoagulation Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Anticoagulation Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
神経再生療法の世界市場（～2026年） Market Analysis and Insights: Global Neuroregeneration Therapy Market The global Neuroregeneration Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…- 画期的治療薬の世界市場（～2026年） Breakthrough therapy drugs are intended to treat serious and life-threatening conditions. The breakthrough therapy is the designation given by FDA for the drugs when there is a preliminary clinical evidence indicates that the drug proves a substantial improvement over available drug treatment. Two f…
- 膵臓がん治療の世界市場（～2026年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
- 強皮症治療ソリューションの世界市場（～2026年） Market Analysis and Insights: Global Scleroderma Therapy Solutions Market The global Scleroderma Therapy Solutions market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 併用抗体療法の世界市場（～2026年） Combination antibody therapy is receiving higher recognition from the oncological branch of medical science research. This is primarily due to the growing use of combination therapy over single drug treatments such as radiation or chemotherapy. In addition, companies that manufacture combination ant…